189 related articles for article (PubMed ID: 26749113)
1. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia.
Bjoraker KJ; Swanson MA; Coughlin CR; Christodoulou J; Tan ES; Fergeson M; Dyack S; Ahmad A; Friederich MW; Spector EB; Creadon-Swindell G; Hodge MA; Gaughan S; Burns C; Van Hove JL
J Pediatr; 2016 Mar; 170():234-9. PubMed ID: 26749113
[TBL] [Abstract][Full Text] [Related]
2. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
Chien YH; Hsu CC; Huang A; Chou SP; Lu FL; Lee WT; Hwu WL
J Child Neurol; 2004 Jan; 19(1):39-42. PubMed ID: 15032382
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia.
Tsuyusaki Y; Shimbo H; Wada T; Iai M; Tsuji M; Yamashita S; Aida N; Kure S; Osaka H
Brain Dev; 2012 Jan; 34(1):72-5. PubMed ID: 21316884
[TBL] [Abstract][Full Text] [Related]
4. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia.
Viola A; Chabrol B; Nicoli F; Confort-Gouny S; Viout P; Cozzone PJ
Pediatr Res; 2002 Aug; 52(2):292-300. PubMed ID: 12149509
[TBL] [Abstract][Full Text] [Related]
6. Late-onset nonketotic hyperglycinemia caused by a novel homozygous missense mutation in the GLDC gene.
Brunel-Guitton C; Casey B; Coulter-Mackie M; Vallance H; Hewes D; Stockler-Ipsiroglu S; Mercimek-Mahmutoglu S
Mol Genet Metab; 2011 Jun; 103(2):193-6. PubMed ID: 21411353
[TBL] [Abstract][Full Text] [Related]
7. Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation.
Korman SH; Wexler ID; Gutman A; Rolland MO; Kanno J; Kure S
Ann Neurol; 2006 Feb; 59(2):411-5. PubMed ID: 16404748
[TBL] [Abstract][Full Text] [Related]
8. The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops).
Magwebu ZE; Mazinu M; Abdul-Rasool S; Chauke CG
Metab Brain Dis; 2019 Oct; 34(5):1467-1472. PubMed ID: 31230217
[TBL] [Abstract][Full Text] [Related]
9. Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation.
Korman SH; Boneh A; Ichinohe A; Kojima K; Sato K; Ergaz Z; Gomori JM; Gutman A; Kure S
Ann Neurol; 2004 Jul; 56(1):139-43. PubMed ID: 15236413
[TBL] [Abstract][Full Text] [Related]
10. [Amplitude-integrated electroencephalography in non-ketotic hyperglycinaemia].
Knaepper-Martin S; Boix H
Rev Neurol; 2014 Jan; 58(1):47. PubMed ID: 24343542
[TBL] [Abstract][Full Text] [Related]
11. High-frequency rhythmic cortical myoclonus in a long-surviving patient with nonketotic hypergylcemia.
Mastrangelo M; Canafoglia L; Franceschetti S; Oppezzo C; Mosca F; Menni F; Parini R; Ciano C; Scaioli V; Panzica F
J Child Neurol; 2008 Mar; 23(3):321-4. PubMed ID: 18182648
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia.
Swanson MA; Coughlin CR; Scharer GH; Szerlong HJ; Bjoraker KJ; Spector EB; Creadon-Swindell G; Mahieu V; Matthijs G; Hennermann JB; Applegarth DA; Toone JR; Tong S; Williams K; Van Hove JL
Ann Neurol; 2015 Oct; 78(4):606-18. PubMed ID: 26179960
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium benzoate in the treatment of atypical nonketotic hyperglycinaemia.
Neuberger JM; Schweitzer S; Rolland MO; Burghard R
J Inherit Metab Dis; 2000 Feb; 23(1):22-6. PubMed ID: 10682305
[TBL] [Abstract][Full Text] [Related]
15. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
[TBL] [Abstract][Full Text] [Related]
16. [Non-ketotic hyperglycinemia: clinical and therapeutic course in three patients].
Rite Gracia S; Guallarte Alias MP; Martínez Moral M; Baldellou Vázquez A; Rite Montañés S; Ruiz-Echarri Zalaya MP; Marco Tello A; Rebage Moisés V
An Esp Pediatr; 1999 Apr; 50(4):408-10. PubMed ID: 10356838
[No Abstract] [Full Text] [Related]
17. Neonatal nonketotic hyperglycinemia.
Bhamkar RP; Colaco P
Indian J Pediatr; 2007 Dec; 74(12):1124-6. PubMed ID: 18174652
[TBL] [Abstract][Full Text] [Related]
18. Glycine decarboxylase deficiency-induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level.
Riché R; Liao M; Pena IA; Leung KY; Lepage N; Greene NDE; Sarafoglou K; Schimmenti LA; Drapeau P; Samarut É
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385710
[TBL] [Abstract][Full Text] [Related]
19. Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.
Van Hove JL; Vande Kerckhove K; Hennermann JB; Mahieu V; Declercq P; Mertens S; De Becker M; Kishnani PS; Jaeken J
J Inherit Metab Dis; 2005; 28(5):651-63. PubMed ID: 16151895
[TBL] [Abstract][Full Text] [Related]
20. Nonketotic hyperglycinemia in two siblings with neonatal seizures.
Wattanasirichaigoon D; Visudtibhan A; Phudhichareonrat S; Chiemchanya S; Leelahagul P; Suwan K; Supapannachart S
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):202-7. PubMed ID: 12971536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
